White House to share COVID-19 technology innovated by US government with the WHO in effort to fight pandemic overseas
- The White House plans to share COVID-19 related technological innovations with the WHO in an effort to fight the pandemic overseas
- The move is expected to be announced by federal health officials on Thursday
- Expansion of access of medical technology, especially in the developed world, has been a priority of the WHO in recent months
- Moderna’s vaccine will not be included, reports say, despite the jab being sought after by many developing nations
<!–
<!–
<!–
<!–
<!–
(function (src, d, tag){
var s = d.createElement(tag), prev = d.getElementsByTagName(tag)[0];
s.src = src;
prev.parentNode.insertBefore(s, prev);
}(“https://www.dailymail.co.uk/static/gunther/1.17.0/async_bundle–.js”, document, “script”));
<!–
DM.loadCSS(“https://www.dailymail.co.uk/static/gunther/gunther-2159/video_bundle–.css”);
<!–
The White House is planning on sharing American-invented COVID-19 technology with the World Health Organization (WHO) in an effort to fight the pandemic across the world.
The Biden Administration is reportedly planning on announcing the initiative to share U.S. scientific breakthrough with the rest of the world Thursday.
Technologies developed by the National Institutes of Health (NIH) will be licensed to the WHO and the Medicines Patent Pool – a United Nations medical group – which will allow other countries to access and replicate the findings.
Developing countries that do not have the same capabilities as the U.S. and other developed nations are set to benefit the most from this agreement. The WHO has long called for richer nations to do more to help their peers, especially in Africa.
The White House is expected to announce on Thursday that it will collaborate with the WHO and the U.N. to share American COVID-19 technology with the rest of the world in an effort to fight the pandemic globally
The highly sought after Moderna COVID-19 vaccine will not be included in the technologies shared by the White House
What technology will exactly be shared is still unknown pending the White House announcement.
The Washington Post reports that technology developed for the Moderna vaccine, which the NIH is suing the company for inventor credit, will not be included.
Moderna vaccine technology may be the most sought after in the world by developing nations, and its failure to be included limits the effectiveness of this plan.
The Cambridge, Massachusetts, based company has said it will not enforce its patent if a replica of it is developed.
While it is still a measure far short of licensing the drug to be manufactured generically, it does open the door for foreign scientists to recreate the drug themselves without fear of legal repercussions.
Afrigen Biologics, a South African company, even managed to successfully replicate a small dosage of the vaccine in a laboratory last month.
- ‘We are going to have a pretty normal spring and summer’:… Elderly recipients of the JJ vaccine were more than FIVE…
It may be years until a vaccine clone is viable to be used in the developing world, though, so calls for Moderna to make vaccine technology more accessible persist.
Other vaccine and Covid treatment technology developed by private companies with assistance from the federal government is also not expected to be included, per the Post.
Experts are still hopeful that this move by the U.S. could spur more cooperation in fighting the pandemic around the world.
‘The U.S. government sets the tone for country relationships toward the pharmaceutical industry, as well as this sort of global cooperation,’ said Peter Maybarduk, director at Public Citizen, told the Post.
‘And by taking the publicly owned inventions, and working with WHO to make them available to humanity … that is a clear and powerful demonstration of what governments can do.’
The move comes as the U.S. transitions towards the end stages of the pandemic.
Earlier this week, the White House announced a shift in its COVID-19 response going forward.
The plan includes ramping up domestic production of tests, antivirals and masks, expanding access to public health resources and information, helping Americans manage ‘long Covid’ symptoms.
It also launched the ‘Test to Treat’ program, which should expand access to Covid therapeutics by making them available for free to any American who tests positive for the virus at any pharmacy-clinic.
The plan also gives funding to schools and daycare centers to improve their ability to prevent transmission, supplying them with Covid tests and resources needed to improve ventilation.
Comments
Share what you think
Newest
Oldest
Best rated
Worst rated
The comments below have not been moderated.
The views expressed in the contents above are those of our users and do not necessarily reflect the views of MailOnline.
Close
Do you want to automatically post your MailOnline comments to your Facebook Timeline?
Your comment will be posted to MailOnline as usual.
Close
Do you want to automatically post your MailOnline comments to your Facebook Timeline?
Your comment will be posted to MailOnline as usual
We will automatically post your comment and a link to the news story to your Facebook timeline at the same time it is posted on MailOnline. To do this we will link your MailOnline account with your Facebook account. We’ll ask you to confirm this for your first post to Facebook.
You can choose on each post whether you would like it to be posted to Facebook. Your details from Facebook will be used to provide you with tailored content, marketing and ads in line with our Privacy Policy.